These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21682298)

  • 1. Discovery of a selective allosteric M1 receptor modulator with suitable development properties based on a quinolizidinone carboxylic acid scaffold.
    Kuduk SD; Chang RK; Di Marco CN; Pitts DR; Greshock TJ; Ma L; Wittmann M; Seager MA; Koeplinger KA; Thompson CD; Hartman GD; Bilodeau MT; Ray WJ
    J Med Chem; 2011 Jul; 54(13):4773-80. PubMed ID: 21682298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel M(1) allosteric ligands: a patent review.
    Kuduk SD; Beshore DC
    Expert Opin Ther Pat; 2012 Dec; 22(12):1385-98. PubMed ID: 23092292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M(1) positive allosteric modulators.
    Kuduk SD; Di Marco CN; Saffold JR; Ray WJ; Ma L; Wittmann M; Koeplinger KA; Thompson CD; Hartman GD; Bilodeau MT; Beshore DC
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1417-20. PubMed ID: 24485781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.
    Sams AG; Hentzer M; Mikkelsen GK; Larsen K; Bundgaard C; Plath N; Christoffersen CT; Bang-Andersen B
    J Med Chem; 2010 Sep; 53(17):6386-97. PubMed ID: 20684563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of LY593093, an M1 muscarinic acetylcholine receptor-selective partial orthosteric agonist.
    Watt ML; Schober DA; Hitchcock S; Liu B; Chesterfield AK; McKinzie D; Felder CC
    J Pharmacol Exp Ther; 2011 Aug; 338(2):622-32. PubMed ID: 21558436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolizidinone carboxylic acid selective M1 allosteric modulators: SAR in the piperidine series.
    Kuduk SD; Chang RK; Di Marco CN; Ray WJ; Ma L; Wittmann M; Seager MA; Koeplinger KA; Thompson CD; Hartman GD; Bilodeau MT
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1710-5. PubMed ID: 21324684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model.
    Puri V; Wang X; Vardigan JD; Kuduk SD; Uslaner JM
    Behav Brain Res; 2015; 287():96-9. PubMed ID: 25800972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using cholinergic M1 receptor positive allosteric modulators to improve memory via enhancement of brain cholinergic communication.
    Chambon C; Jatzke C; Wegener N; Gravius A; Danysz W
    Eur J Pharmacol; 2012 Dec; 697(1-3):73-80. PubMed ID: 23085025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Approach to Discovering Novel Muscarinic M
    Kurimoto E; Matsuda S; Shimizu Y; Sako Y; Mandai T; Sugimoto T; Sakamoto H; Kimura H
    J Pharmacol Exp Ther; 2018 Jan; 364(1):28-37. PubMed ID: 29025977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptor.
    Keov P; Valant C; Devine SM; Lane JR; Scammells PJ; Sexton PM; Christopoulos A
    Mol Pharmacol; 2013 Sep; 84(3):425-37. PubMed ID: 23798605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs).
    Kuduk SD; Beshore DC
    Curr Top Med Chem; 2014; 14(15):1738-54. PubMed ID: 25176125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor.
    Mistry SN; Valant C; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
    J Med Chem; 2013 Jun; 56(12):5151-72. PubMed ID: 23718562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors.
    Alt A; Pendri A; Bertekap RL; Li G; Benitex Y; Nophsker M; Rockwell KL; Burford NT; Sum CS; Chen J; Herbst JJ; Ferrante M; Hendricson A; Cvijic ME; Westphal RS; O'Connell J; Banks M; Zhang L; Gentles RG; Jenkins S; Loy J; Macor JE
    J Pharmacol Exp Ther; 2016 Feb; 356(2):293-304. PubMed ID: 26582730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects.
    Valant C; Felder CC; Sexton PM; Christopoulos A
    Mol Pharmacol; 2012 Jan; 81(1):41-52. PubMed ID: 21989256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of transmembrane domain 3 in the actions of orthosteric, allosteric, and atypical agonists of the M4 muscarinic acetylcholine receptor.
    Leach K; Davey AE; Felder CC; Sexton PM; Christopoulos A
    Mol Pharmacol; 2011 May; 79(5):855-65. PubMed ID: 21300722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The M1 muscarinic receptor allosteric agonists AC-42 and 1-[1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one bind to a unique site distinct from the acetylcholine orthosteric site.
    Jacobson MA; Kreatsoulas C; Pascarella DM; O'Brien JA; Sur C
    Mol Pharmacol; 2010 Oct; 78(4):648-57. PubMed ID: 20660086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M(1) receptor: direct pharmacological evidence that AC-42 is an allosteric agonist.
    Langmead CJ; Fry VA; Forbes IT; Branch CL; Christopoulos A; Wood MD; Herdon HJ
    Mol Pharmacol; 2006 Jan; 69(1):236-46. PubMed ID: 16207821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor.
    Mistry SN; Jörg M; Lim H; Vinh NB; Sexton PM; Capuano B; Christopoulos A; Lane JR; Scammells PJ
    J Med Chem; 2016 Jan; 59(1):388-409. PubMed ID: 26624844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model.
    Bradley SR; Lameh J; Ohrmund L; Son T; Bajpai A; Nguyen D; Friberg M; Burstein ES; Spalding TA; Ott TR; Schiffer HH; Tabatabaei A; McFarland K; Davis RE; Bonhaus DW
    Neuropharmacology; 2010 Feb; 58(2):365-73. PubMed ID: 19835892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors.
    May LT; Avlani VA; Langmead CJ; Herdon HJ; Wood MD; Sexton PM; Christopoulos A
    Mol Pharmacol; 2007 Aug; 72(2):463-76. PubMed ID: 17525129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.